Company intelligence / Profile preview

Blueprint Local

Cambridge, Massachusetts, United Statesblueprint-local.com ↗

Ownership: Private
Development stage: Other

Overview

Blueprint Medicines has developed and commercialized avapritinib for multiple forms of systemic mastocytosis and certain gastrointestinal stromal tumors. The company also advanced elenestinib and BLU‑808 into clinical development targeting additional allergic/inflammatory conditions. Its pipeline includes both approved drugs and investigational therapies at various stages. Clinical results have demonstrated efficacy in rare hematologic malignancies and solid tumors driven by specific genetic alterations.

Therapeutic areas: OncologyDermatologyImmunologyHematology
Modalities: Small moleculeKinase inhibitor
Industry: Biotech

Partnerships

Roche/F. Hoffmann-La Roche Ltd – collaboration on up to five small-molecule therapeutics targeting kinases important in cancer immunotherapyRoyalty Pharma – royalty monetization agreementSixth Street – strategic financing partner

Beyond the preview

Go deeper on Blueprint Local.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blueprint Local.

Explore the full profile